Effects of iloprost on human mature osteoblasts in vitro.

BACKGROUND AND OBJECTIVES Bone marrow oedema is a multifactorial conditioned illness. Alongside any strain relief of an affected joint, treatment with Iloprost also belongs to the choice of cures. In past studies, a modulatory effect on bone could be shown. The hypothesis of the present work is that Iloprost has a growth-stimulating effect on osteoblasts in vitro. METHODS Human osteoblasts were isolated and cultivated. Subsequently, the cells were treated with Iloprost in bioavailable concentrations. Alterations of the cell structure were examined by means of light microscopy. A regulation of the number of vital cells was carried out by using a CASY cell counter. Possible cell impairment after Iloprost treatment was analysed by means of XTT Elisa as well as FDA and PI staining via fluorescence microscopy. RESULTS Using light microscopy, no changes in cell structure could be observed. With the CASY cell counter, no increase in the numbers of osteoblasts appeared after Iloprost treatment. Also, XTT Elisas and fluorescence microscopy did not reveal any cell impairment due to Iloprost. CONCLUSION Our results could not confirm a modulatory effect in mature osteoblasts. On the basis of the present work we could not verify any growth-stimulating effect by Iloprost in mature osteoblasts in vitro. Admittedly, effects had been shown previously during osteogenesis, but we do exclude an effect on mature osteoblasts which have already differentiated.

[1]  P. Giannoudis,et al.  The role of Iloprost on bone edema and osteonecrosis: Safety and clinical results , 2018, Expert opinion on drug safety.

[2]  P. Richards,et al.  Prostaglandin E2 inhibits matrix mineralization by human bone marrow stromal cell-derived osteoblasts via Epac-dependent cAMP signaling , 2017, Scientific Reports.

[3]  D. Prior,et al.  Update on pharmacotherapy for pulmonary hypertension , 2016, The Medical journal of Australia.

[4]  S. Landgraeber,et al.  Long-term Clinical Results after Iloprost Treatment for Bone Marrow Edema and Avascular Necrosis , 2016, Orthopedic reviews.

[5]  M. Murad,et al.  A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers. , 2016, Journal of vascular surgery.

[6]  C. Perka,et al.  Effects of intravenous iloprost therapy in patients with bone marrow oedema of the foot and ankle , 2014, European Journal of Orthopaedic Surgery & Traumatology.

[7]  J. Fischer,et al.  Prostacyclin Suppresses Twist Expression in the Presence of Indomethacin in Bone Marrow-Derived Mesenchymal Stromal Cells , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[8]  D. Blondin,et al.  Efficiency of iloprost treatment for osseous malperfusion , 2011, International Orthopaedics.

[9]  S. Iturria,et al.  Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats. , 2008, Bone.

[10]  G. Petje,et al.  MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost , 2005, Wiener klinische Wochenschrift.

[11]  H. Erli,et al.  Beeinflussung humaner Osteoblasten durch verschiedene Analgetika , 2002, Der Unfallchirurg.

[12]  K. Klaushofer,et al.  Prostacyclin (PGI2): a potential mediator of c‐fos expression induced by hydrostatic pressure in osteoblastic cells , 1996, European journal of clinical investigation.

[13]  H. Kawaguchi,et al.  The role of prostaglandins in the regulation of bone metabolism. , 1995, Clinical orthopaedics and related research.

[14]  G. Hunder,et al.  Transient Regional Osteoporosis: A Study of 56 Cases and Review of the Literature , 1987 .

[15]  S. Dekel,et al.  Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits. , 1981, The Journal of bone and joint surgery. British volume.

[16]  Cato T Laurencin,et al.  Bone tissue engineering: recent advances and challenges. , 2012, Critical reviews in biomedical engineering.

[17]  O. Paar,et al.  [Modification of human osteoblasts by various analgesics]. , 2002, Der Unfallchirurg.

[18]  G. Rodan,et al.  The role of prostaglandins in bone formation. , 1995, Connective tissue research.

[19]  W. Jee,et al.  Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat. , 1993, Bone and mineral.

[20]  W. Jee,et al.  Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats. , 1991, Bone and mineral.

[21]  D B Kimmel,et al.  Effects of prostaglandin E2 on production of new cancellous bone in the axial skeleton of ovariectomized rats. , 1990, Bone.